Ananda Developments - Total Voting Rights
Announcement provided by
Ananda Developments Plc · ANA30/09/2024 07:00
30 September 2024
Ananda Developments plc
("Ananda Developments" or the "Company")
Total Voting Rights
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Ananda announces that the Company has 3,619,980,106 ordinary shares of 0.2p each in issue ("Ordinary Shares"), each share carrying the right to one vote.
This figure of 3,619,980,106 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
To stay up to date with the latest developments at Ananda, we encourage you to follow and join our social media channels which are:
· Register at our Investor Hub: https://investors.anandadevelopments.com/s/a66906
· Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
· LinkedIn: https://www.linkedin.com/company/anadevelopments/
· Twitter: https://twitter.com/AnandaPlc
· Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
InvestorHub Engage with us directly at Ananda Developments Investor Hub
|
Sign up at https://investors.anandadevelopments.com/s/a66906
|
ANANDA DEVELOPMENTS PLC Chief Executive Officer Melissa Sturgess
Jeremy Sturgess-Smith
|
+44 (0)7463 686 497 ir@anandadevelopments.com |
SP ANGEL CORPORATE FINANCE LLP Corporate Finance Richard Morrison Caroline Rowe |
+44 (0)20 3470 0470 |
Corporate Broking Abigail Wayne Rob Rees
|
|
Yellow Jersey PR Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512
|
About Ananda Developments
Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions
For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/s/a66906.
https://investors.anandadevelopments.com/link/pegp0r
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.